Catalyst Wire Dossier Catalyst Wire Dossier

Lotemax 0.5%

loteprednol etabonate
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Lotemax 0.5%, covering 2018-10-22 to 2018-10-22. Get the full timeline:

Most recent: Clinical Trial Update: Clinical Outcomes and Evaluation of Lotemax 0.5% in Treatment of Ocular Inflammation Associated With Cataract Surgery

See pricing